On February 7, 2025, John Owen Brennan notified the Secretary of ImmunityBio, Inc., a Delaware corporation (the “Company”) of his resignation as a member of the Company’s Board of Directors (the “Board”) and from all committees of the Board on which he served, effective as of February 7, 2025.
On February 4, 2025, Robin L. Washington notified the Board of Directors (the “Board”) of Vertiv Holdings Co (the “Company”) that she has decided to resign from the Board, effective as of March 31, 2025, in light of her recently announced appointment to serve as President and Chief Operating and Financial Officer of Salesforce, Inc.
the Board additionally approved the expansion of the Board to ten directors and the appointment of Mr. Tuweiq as a director on the Board in the class of directors whose terms expire at the 2025 Annual Meeting, with such expansion and appointment to be effective as of the date of the 2025 Annual Meeting.
On February 3, 2025, the Board of Directors (“Board”) of Aqua Metals, Inc. (“Company”), acting upon the recommendation of the Board’s Nominating and Corporate Governance Committee, appointed Steve Henderson and Eric Gangloff to the Board.
On February 3, 2025, the Board of Directors (“Board”) of Aqua Metals, Inc. (“Company”), acting upon the recommendation of the Board’s Nominating and Corporate Governance Committee, appointed Steve Henderson and Eric Gangloff to the Board.
On February 4, 2025, the Company appointed three directors (the “New Directors”) to its board of directors (the “Board of Directors”). The New Directors are Liberty Duke, Mark Meller and Gerald Dial.
On February 4, 2025, the Company appointed three directors (the “New Directors”) to its board of directors (the “Board of Directors”). The New Directors are Liberty Duke, Mark Meller and Gerald Dial.
On February 4, 2025, the Company appointed three directors (the “New Directors”) to its board of directors (the “Board of Directors”). The New Directors are Liberty Duke, Mark Meller and Gerald Dial.
On February 4, 2025, Wan Ling Martello, a member of the board of directors of Uber Technologies, Inc. (the “Company”), informed the Company of her intention not to stand for re-election at the Company’s 2025 Annual Meeting of Shareholders in May.
On February 5, 2025, the Board of Directors (the “Board”) of Norwegian Cruise Line Holdings Ltd. (“NCLH”) appointed Mr. John Chidsey as a member of the Board.
Appointed
John Chidsey
Director
NCL CORP Ltd.
Effective
2025-02-05
Filed
February 7, 2025, 6:59 PM ET
On February 5, 2025, the Board of Directors (the “Board”) of Norwegian Cruise Line Holdings Ltd. (“NCLH”), which is the direct parent company of NCL Corporation Ltd. (“NCLC”), appointed Mr. John Chidsey as a member of the Board.
On February 5, 2025, the Board of Directors of Arrowhead Pharmaceuticals, Inc. (the “Company”) appointed Douglas Ingram as a director of the Company, effective February 6, 2025.
On February 6, 2025, Mr. Joseph Grimes, Mr. Sanjay Prasad and Mr. Steven Ritacco, each resigned from the Board of Directors of TRIBAL RIDES INTERNATIONAL CORP.
On February 6, 2025, Mr. Joseph Grimes, Mr. Sanjay Prasad and Mr. Steven Ritacco, each resigned from the Board of Directors of TRIBAL RIDES INTERNATIONAL CORP.
On February 6, 2025, Mr. Joseph Grimes, Mr. Sanjay Prasad and Mr. Steven Ritacco, each resigned from the Board of Directors of TRIBAL RIDES INTERNATIONAL CORP.
On February 4, 2025, Arch Capital Group Ltd.’s (“ACGL”) Board of Directors (“Board”) unanimously approved the appointment of Alexander Moczarski to serve as a Class III director of the Board, effective February 4, 2025.
On February 2, 2025, Gail Schulze, a member of the class of directors whose terms of office expire at the 2025 annual meeting of stockholders (the “2025 Annual Meeting”) of Cerus Corporation (the “Company”), informed the Company that she would not stand for re-election at the 2025 Annual Meeting.
On February 5, 2025, Lara H. Balazs notified the Board of Directors of Frontdoor, Inc. (the “Company”) that she does not intend to stand for re-election as a director of the Company when her term expires at the Company’s 2025 annual meeting of stockholders.
On February 4, 2025, Herbert Simon, age 90, a member and Chaiman Emeritus of the Board of Directors (the “Board”) of Simon Property Group, Inc. (the “Company”) notified the Company that he is retiring from the Board, including his position as Chairman Emeritus, effective as of such date.
On February 27, 2024, Mr. Keijiero Varela tendered his resignation, effective March 12, 2024 (the “Effective Date”), as Director of The Cannaisseur Group, Inc. (the “Company”), to pursue other business opportunities.
On December 4, 2024, Mr. Harold "Butch" Woolfolk tendered his resignation, effective December 13, 2024 (the "Effective Date"), as Director of The Cannaisseur Group, Inc. (the "Company"), to pursue other business opportunities.
On February 6, 2025, Sabre Corporation (“Sabre”) announced that Karl Peterson will be retiring from the Board, as well as from all Board committees on which he sits, effective immediately prior to Sabre’s 2025 Annual Meeting of Stockholders, which is scheduled to be held on April 23, 2025.
Departed
Angus C. Russell
director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Departed
Chris Nolet
director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Departed
Vlad Coric
director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Departed
Julian S. Gangolli
director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Departed
Jill Beraud
director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Appointed
Jeffery A Bedard
director
Revance Therapeutics, Inc.
Effective
2025-02-06
Filed
February 6, 2025, 6:59 PM ET
Jeffery A Bedard became the sole director of the Company.
Departed
Olivia C. Ware
director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Departed
Mark J. Foley
director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Departed
Carey O’Connor Kolaja
director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
On February 6, 2025, the Board of Directors (the “Board”) of Block, Inc. (the “Company”) increased the size of the Board from nine to ten directors and elected Anthony Eisen to the Board as a Class III director, effective February 6, 2025.
Pursuant to the terms of the Merger Agreement, the Board of Directors (the "Board") of the Company approved an increase of the size of the Board from 7 to 8 members effective February 5, 2025 and filled the newly created vacancy by appointing Peter R. Sachse, as an independent director, to serve on the Board, effective on the same day.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.